These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1069 related items for PubMed ID: 15205322
21. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT. Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630 [Abstract] [Full Text] [Related]
22. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression. Geradts J, Wilentz RE, Roberts H. Mod Pathol; 2001 Nov 09; 14(11):1162-8. PubMed ID: 11706079 [Abstract] [Full Text] [Related]
23. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N. Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621 [Abstract] [Full Text] [Related]
24. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. Silva J, Silva JM, Domínguez G, García JM, Cantos B, Rodríguez R, Larrondo FJ, Provencio M, España P, Bonilla F. J Pathol; 2003 Mar 01; 199(3):289-97. PubMed ID: 12579530 [Abstract] [Full Text] [Related]
25. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM. Clin Cancer Res; 1996 Dec 01; 2(12):1993-8. PubMed ID: 9816158 [Abstract] [Full Text] [Related]
26. The Pezcoller lecture: cancer cell cycles revisited. Sherr CJ. Cancer Res; 2000 Jul 15; 60(14):3689-95. PubMed ID: 10919634 [Abstract] [Full Text] [Related]
27. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y. Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420 [Abstract] [Full Text] [Related]
28. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Bastide K, Guilly MN, Bernaudin JF, Joubert C, Lectard B, Levalois C, Malfoy B, Chevillard S. Lung Cancer; 2009 Mar 18; 63(3):348-53. PubMed ID: 18656278 [Abstract] [Full Text] [Related]
29. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis. Tang S, Luo H, Yu J, Yang D, Shu J. Chin Med J (Engl); 2003 Jul 18; 116(7):1083-7. PubMed ID: 12890389 [Abstract] [Full Text] [Related]
30. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM. Cancer Res; 2002 Sep 15; 62(18):5295-300. PubMed ID: 12234999 [Abstract] [Full Text] [Related]
31. The INK4a/ARF locus and melanoma. Sharpless E, Chin L. Oncogene; 2003 May 19; 22(20):3092-8. PubMed ID: 12789286 [Abstract] [Full Text] [Related]
32. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS. Arch Otolaryngol Head Neck Surg; 2006 Apr 19; 132(4):409-15. PubMed ID: 16618910 [Abstract] [Full Text] [Related]
33. p53 Deficiency leads to compensatory up-regulation of p16INK4a. Leong WF, Chau JF, Li B. Mol Cancer Res; 2009 Mar 19; 7(3):354-60. PubMed ID: 19240179 [Abstract] [Full Text] [Related]
34. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
35. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J, Sidransky D. Oncogene; 1999 Oct 21; 18(43):5843-9. PubMed ID: 10557071 [Abstract] [Full Text] [Related]
36. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T. Hum Pathol; 2009 Jun 21; 40(6):817-26. PubMed ID: 19200577 [Abstract] [Full Text] [Related]
37. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis]. Soufir N, Basset-Seguin N. Bull Cancer; 2001 Nov 21; 88(11):1061-7. PubMed ID: 11741799 [Abstract] [Full Text] [Related]
38. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast. Geradts J, Ingram CD. Mod Pathol; 2000 Sep 21; 13(9):945-53. PubMed ID: 11007034 [Abstract] [Full Text] [Related]
39. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Robertson KD, Jones PA. Oncogene; 1999 Jul 01; 18(26):3810-20. PubMed ID: 10445844 [Abstract] [Full Text] [Related]
40. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis. Oda Y, Yamamoto H, Takahira T, Kobayashi C, Kawaguchi K, Tateishi N, Nozuka Y, Tamiya S, Tanaka K, Matsuda S, Yokoyama R, Iwamoto Y, Tsuneyoshi M. J Pathol; 2005 Dec 01; 207(4):410-21. PubMed ID: 16177957 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]